MIMEDX, INC.

Company News

MiMedx to Present at 36th Annual J.P. Morgan Healthcare Conference

MARIETTA, Ga., Jan. 2, 2018 - MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference. Parker H. "Pete" Petit,...

Read More »
Company News

MiMedx Agrees to Lawsuit Settlement with Former Employee

MARIETTA, Ga., Dec. 19, 2017 - MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that the Company has agreed to a confidential lawsuit settlement from one former employee. MiMedx has...

Read More »

All Topics